Serving approximately 3,000 customers across 12 facilities in the United States, Mexio, Asia and Europe, Nelson Labs is a global leader in outsourced microbiological and analytical chemistry testing ...

The Pharmaceutical Industry has a diverse set of products all with varying level of microbial risk to patients. On the low risk extreme there are topical pharmaceuticals on the other extreme are the ...

DUBLIN--(BUSINESS WIRE)--The "Bioburden Testing Market by Product, Test, Application, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. The bioburden ...

Swiss CDMO Lonza is making a move to strengthen and speed up quality control testing with the purchase of French rapid ...

The quality of water for pharmaceutical production (purified water, water for injection, and ultrapure water) is quantified and regulated through four parameters – total organic carbon (TOC), ...

On May 26, 2020, the U.S. Food and Drug Administration (“FDA” or “Agency”) issued an immediately in effect guidance, Recommendations for Sponsors Requesting EUAs for Decontamination and Bioburden ...

WILMINGTON, Mass.—October 20, 2014 – Charles River Laboratories International, Inc. (NYSE: CRL) today introduced the PTS-Micro™ system, a new technology platform designed for rapid microbial burden ...

BILLERICA, Mass., July 30, 2014 /PRNewswire/ -- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, has launched the EZ-Fit(TM) Filtration Unit, a ready-to-use, disposable ...

Lonza, a CDMO, has signed an agreement to acquire Redberry SAS, a company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology.

Nelson Labs is expanding its Wiesbaden facility to enhance packaging validation and microbiological testing capabilities for medical device and pharmaceutical customers. The expansion includes new ...